Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Bre... (s shouldmaintain good oral hygiene and s...)

HOME >> MEDICINE >> TECHNOLOGY

Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer

Date:5/31/2008

s should maintain good oral hygiene and should have a dental examination with preventive dentistry prior to treatment with bisphosphonates. While on treatment, these patients should avoid invasive dental procedures, if possible. No data are available as to whether discontinuation of bisphosphonate therapy reduces the risk of ONJ in patients requiring dental procedures. A causal relationship between bisphosphonate use and ONJ has not been established. Clinical judgment of the treating physician should guide the management plan of each patient based on individual benefit/risk assessment.

In postmarketing experience, severe and occasionally incapacitating bone, joint, and/or muscle pain has been reported infrequently in patients taking bisphosphonates.

The most common adverse events (greater than or equal to 15%) in bone metastases clinical trials, regardless of causality, with Zometa 4 mg (n=1031) were as follows: bone pain (55%), nausea (46%), fatigue (39%), anemia (33%), pyrexia (32%), vomiting (32%), constipation (31%), dyspnea (27%), diarrhea (24%), weakness (24%), myalgia (23%), anorexia (22%), cough (22%), arthralgia (21%), lower-limb edema (21%), malignant neoplasm aggravated (20%), headache (19%), dizziness (excluding vertigo) (18%), insomnia (16%), decreased weight (16%), back pain (15%), and paresthesia (15%).

Caution is advised when bisphosphonates are administered with aminoglycosides, loop diuretics, and potentially nephrotoxic drugs.

Zometa contains the same active ingredient as found in Reclast(R) (zoledronic acid). Patients being treated with Zometa should not be treated with Reclast.

Patients should be administered an oral calcium supplement of 500 mg and a multiple vitamin containing 400 IU of vitamin D daily.

Please see full Prescribing Information.

Disclaimer

The foregoing release contains forward-looking statements that can be identified by terminology such as "may", "continue to", "anticipat
'/>"/>

SOURCE Novartis
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9
Related medicine technology :

1. Video: The Journal, Human Genetics, Publishes Results Supporting Interleukin Genetics Heart Health Test
2. VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy
3. Video: New Results From One of the Worlds Largest Breast Cancer Trials Herald Hope for Thousands of Women
4. Video: Quest Diagnostics Health Trends(TM) Report Shows Significant Gap in Care for Patients With Chronic Kidney Disease
5. Video: Actress and New Mom Keri Russell Joins PKIDs to Launch Silence the Sounds of Pertussis Campaign
6. Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies
7. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
8. Video: New Research Discovers Independent Brain Networks Control Human Walking
9. BioElectronics Announces Major Clinical Trials
10. XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years
11. New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting

Post Your Comments:

(Date:5/21/2013)... , May 21, 2013 RxAlly , ... nationwide, announces today the publication of a white ... Health Care System. The white paper highlights an ... and seeks public engagement to avert strains on ... Care refers to a range of individually-tailored, pharmacist-provided ...

(Date:5/20/2013)... 2013 Volcano Corporation (NASDAQ: VOLC ) ... tools designed to enhance the diagnosis and treatment of ... highlight its efforts to expand research and innovation surrounding ... and iFR ® (Instant Wave-Free Ratio™) 1 ... at EuroPCR 2013 in Paris . ...

(Date:5/20/2013)... Ill. , May 20, 2013 Landauer, ... in personal and environmental radiation measurement and monitoring, outsourced ... announced today that its Board of Directors declared, at ... cash dividend of $0.55 per share for the third ... on July 3, 2013, to shareholders of record on ...

Breaking Medicine Technology:RxAlly Releases White Paper on Necessity of Personalized Pharmacist Care 2 RxAlly Releases White Paper on Necessity of Personalized Pharmacist Care 3 Volcano to Highlight its Physiology Expansion Efforts at EuroPCR 2013 2 Volcano to Highlight its Physiology Expansion Efforts at EuroPCR 2013 3 Volcano to Highlight its Physiology Expansion Efforts at EuroPCR 2013 4 Landauer, Inc. Declares Regular Cash Dividend 2

[0] RxAlly Releases White Paper on Necessity of Personalized Pharmacist Care [0] Volcano to Highlight its Physiology Expansion Efforts at EuroPCR 2013 [0] Landauer, Inc. Declares Regular Cash Dividend

... CARY, N.C., Dec. 18 Cornerstone Therapeutics Inc. (Nasdaq CM: ... commercializing significant products primarily for the respiratory and related markets, ... 8:30 AM ET on Thursday, January 7, 2010, to discuss ... a press release outlining its financial guidance for 2010 prior ...

... , BOSTON, Dec. 18 Solos Endoscopy, Inc. (Pink Sheets: ... a significant design improvement to its MammoView(TM) ductoscope. In January ... stainless steel tip with a much stronger braided polyimide tip. ... made to our ductoscope. One of the major difficulties in ...

Cached Medicine Technology:Cornerstone Therapeutics to Host Conference Call to Discuss Financial Guidance for 2010 2 Cornerstone Therapeutics to Host Conference Call to Discuss Financial Guidance for 2010 3 Solos Endoscopy, Inc. Makes Significant Design Improvement To Its MammoView(TM) Ductoscope 2

Cornerstone Therapeutics to Host Conference Call to Discuss Financial Guidance for 2010 Solos Endoscopy, Inc. Makes Significant Design Improvement To Its MammoView(TM) Ductoscope

(Date:5/21/2013)... 2013 Global Proving Ground (GPG), a ... largest online retailer of health and fitness supplements, are ... show, Warrior Island. “We cast the show by ... Twitter, with our unique social networking platform,” states show’s ... fighters on an island in the Pacific Ocean, where ...

(Date:5/21/2013)... 2013) A paper recently published in the ... physicians and scientists at the University of Colorado School ... for pulmonary fibrosis can be used to identify individuals ... looked at a fairly common variant of the gene ... the mucous produced by the bronchial tubes. While this ...

(Date:5/21/2013)... Department of Defense Serum Repository (DoDSR), University of Cincinnati ... inflammatory bowel disease (IBD), which could help with earlier ... shown symptoms. , This finding, the first of its ... being presented via podium presentation by staff from Walter ... 2013, being held May 18-21 in Orlando, Fla. ...

(Date:5/21/2013)... New York (PRWEB) May 21, 2013 ... surgery robot lawsuit is nearing its conclusion in ... to Bloomberg.com, during closing statements yesterday, an attorney for ... alleging the company wanted to tie sales and services ... all the training to keep control of surgeons, to ...

(Date:5/21/2013)... (PRWEB) May 21, 2013 Go Classy ... today that they have redesigned their website featuring ... beach, pool, hot tubs, bars and dining. The website, ... resort including sales and guest reviews, will now have ... Jamaica itself, including pages on culinary local recipes, flora ...

Breaking Medicine News(10 mins):Health News:Bodybuilding.com Partners with Global Proving Ground’s New Reality Show Warrior Island 2 Health News:Bodybuilding.com Partners with Global Proving Ground’s New Reality Show Warrior Island 3 Health News:Researchers find genetic risk factor for pulmonary fibrosis 2 Health News:Biomarkers discovered for inflammatory bowel disease 2 Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 2 Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 3 Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 4 Health News:The Oldest and Original Nudist Travel Agency for NResort Announced Today a Redesigned Website Featuring Information on Culinary Events, Flora and Fauna, and Photography 2

[0] Bodybuilding.com Partners with Global Proving Ground’s New Reality Show Warrior Island [0] Researchers find genetic risk factor for pulmonary fibrosis [0] Biomarkers discovered for inflammatory bowel disease [0] Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial [0] The Oldest and Original Nudist Travel Agency for NResort Announced Today a Redesigned Website Featuring Information on Culinary Events, Flora and Fauna, and Photography

... Cancer Patients in HELIOS HospitalsBERLIN, March 10 ... gain access to the most modern radiotherapy treatments with ... is acquiring nine linear accelerators from Varian Medical Systems ... equipped with RapidArc(TM) technology for fast and comfortable treatments. ...

... awareness for children and adults with autismFAIRFIELD, Conn. ... Network ( www.AutismSupportNetwork.com ) and the Israeli Society ... announced an international alliance to help foster support ... autism spectrum disorder (ASD). The partnership provides for ...

... March 10 More physician leaders are embracing technological ... consider them clunky and unresponsive to their needs.Those are ... American College of Physician Executives (ACPE). The findings were ... Journal, ACPE,s journal of medical management.ACPE conducted the same ...

... HOUSTON, March 10 InPlace Medical Solutions ... pioneering telemedicine healthcare services for Scorpion Offshore ... ongoing pilot project makes Scorpion Offshore the ... with the full-service system of advanced healthcare, ...

... /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS ... of the Company, will present at the Cowen and Company ... Place, on Wednesday, March 18, 2009 at 11:00 a.m. ET. ... presentation by visiting the "Events" section of the homepage of ...

... Quarter Adjusted FIFO EBITDA Increases 4.3% to $26.1 Million, ... Full Year Adjusted FIFO EBITDA Increases 15% to ... Year Net Cash Provided by Operating Activities Increases 130% ... $17.4 Million and Full Year Net Loss of $72.8 ...

Leading German Healthcare Group Selects Equipment and Software from Varian Medical Systems for Major Replacement Project Autism Support Network and the Israeli Society for Autistic Children Form International Alliance Survey Results: Health Care Technology Advances as Physician Frustration Grows Scorpion Offshore Inc. Pilot Project With InPlace Medical Solutions Sets New Standard for Offshore Medical Services Labopharm to present at Cowen 29th Annual Health Care Conference Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results

The Natural-Knee Family is a complete range of interchangeable, anatomically-designed implants with over 14 years of proven clinical results....

...

Medicine Products:

The Comprehensive Natural-Knee Cruciate Retaining System Lineage Acetabular Poly Liners - 32 mm ID Standard Liners - Hooded 10 degree liners The Protract Hip System - Hooded Liner